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ABSTRACT
The dynamic exchange of histone lysine methylation
status by histone methyltransferases and demethy-
lases has been previously implicated as an import-
ant factor in chromatin structure and transcriptional
regulation. Using immunoaffinity TAP analysis, we
purified the WHISTLE-interacting protein com-
plexes, which include the heat shock protein
HSP90a and the jumonji C-domain harboring the
histone demethylase JMJD1C. In this study, we
demonstrate that JMJD1C specifically demethylates
histone H3K9 mono- and di-methylation, and
mediates transcriptional activation. We also
provide evidence suggesting that both WHISTLE
and JMJD1C performs functions in the development
of mouse testes by regulating the expression of
the steroidogenesis marker, p450c17, via SF-1-
mediated transcription. Furthermore, we demon-
strate that WHISTLE is recruited to the p450c17
promoter via SF-1 and represses the transcription
of prepubertal stages of steroidogenesis, after
which JMJD1C replaces WHISTLE and activates
the expression of target genes via SF-1-mediated
interactions. Our results demonstrate that the
histone methylation balance mediated by HMTase
WHISTLE and demethylase JMJD1C perform a
transcriptional regulatory function in mouse testis
development.
INTRODUCTION
The basic building block of chromatin structure, the nu-
cleosome, is composed of 146bp of DNA wrapped around
a histone octamer (1). A growing body of evidence
suggests that chromatin structure is modulated by a
variety of histone modiﬁcations that perform pivotal regu-
latory functions in the control of gene expression. Histone
methylation has been studied extensively, and recognized
as an essential marker for a variety of biological processes,
including transcriptional regulation. Histone methylation
is known to be facilitated by target lysines and arginine
residues of histones; in particular, the methylation of a
speciﬁc lysine residue results in transcriptional activation
or in the repression of target genes.
Histone lysine demethylation is carried out by two
families of enzymes: the amine oxidases, such as LSD1,
and the hydroxylases of a family of proteins that harbor
the jumonji C (JmjC)-domain (2,3). Considering the
pivotal biological functions that histone methylation has
been shown to perform, histone demethylation is expected
to be involved in the same processes, and with similar
eﬀects (4). Therefore, both histone lysine methylation
and demethylation can be employed to demonstrate the
dynamic status of methylation marks, in addition to their
epigenetic control of transcriptional regulation (5).
Recently, an increasing number of researchers are sug-
gesting that the status of histone methylation is tightly
regulated by HMTases and demethylases in a speciﬁc
target gene, in a tissue-dependent and more importantly,
mutually non-exclusive manner in transcriptional time
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repression methylation markers have been detected in
pluripotent cells via genome-wide proﬁling (6). Physical
interactions occurring between the demethylase UTX
and MLL complexes in the transcriptional regulation of
HOX genes have also been theorized to occur (7,8). The
recruitment of G9a and GLP to the cyclin D1 promoter
via the expression of Jarid2 reﬂects the formation of a
protein complex between the histone-modifying enzymes
(9). Recently, coordinate regulations of histone methyla-
tion and demethylation for the ﬁne control of target gene
transcription have been demonstrated (10,11).
Steroidogenesis begins with the transfer of cholesterol
from the cytoplasm into the inner membranes of
mitochondria by steroidogenic acute regulatory protein
(StAR). A series of sequential conversions of cholesterol
into testosterone involves diﬀerent cleavage enzymes,
including p450scc and p450c17. Steroidogenic factor 1
(SF-1) primarily regulates steroidogenesis in the testes
via the regulation of steroid-synthesizing enzymes (12).
In the regulation of postnatal testicular steroidogenesis,
luteinizing hormone (LH) functions as a primary regulator
and stimulates Leydig cells to generate testosterone (13).
We demonstrated previously that an HMTase
WHISTLE evidences both histone H3K4 and H3K27
methylating activity and transcriptional repression
activity via HDAC recruitment (14). We further demons-
trated that WHISTLE induces caspase-dependent apop-
totic cell death in a SET domain-dependent manner (15).
In this study, we immunoaﬃnity-puriﬁed the WHISTLE-
interacting proteins, including HSP90a and JMJD1C,
and subsequently biochemically characterized their
speciﬁc HMTase cofactor and H3K9 demethylase
activities, respectively. We further present both in vitro
and in vivo evidence suggesting the coordinate regulatory
role of WHISTLE and JMJD1C in steroidogenesis in the
mouse testes. Our ﬁndings demonstrate that the diﬀeren-
tial time-scale occupancy of the steroidogenic marker
p450c17 promoter by WHISTLE and JMJD1C regulates
transcription via interaction with SF-1. We suggest that a
possible transcriptional regulatory mechanism in the de-
velopment of the mouse testes occurs via the coordinated
regulation of histone methylation and demethylation.
MATERIALS AND METHODS
Plasmids
The pGEX-4T1-WHISTLE plasmid was described previ-
ously (14). For the puriﬁcation of TAP, WHISTLE was
cloned into the pNTAP vector (Stratagene) in-frame
with the SBP and CBP aﬃnity tags located at the 50 end
of the fusion gene. pCMV-sport6-JMJD1C (BC068318)
and pCMV-HSP90a (BC023006) were purchased from
Openbiosystems and KUGI, respectively. The partial
regions (amino acids 1836–2487) of the JMJD1C cDNA
were inserted into the pGEX-4T1 bacterial expression
vector (Amersham Biosciences) to construct the
GST-JMJD1C fusion proteins. JMJD1C (H2326A) point
mutants were constructed by Cosmo Genetech. In order to
construct the mammalian expression vectors, we employed
modiﬁed pcDNA6-HA-myc-his (Invitrogen) and used
pFLAG-JMJD1C to create the HA, myc and his-tagged
JMJD1C (H2326A) point mutant and ﬂag-tagged
JMJD1C proteins. The shRNA against mouse
WHISTLE (M-060989-01-0010) was purchased from
Openbiosystems. The siRNAs against mouse JMJD1C
(L-062872-00-0010) and SF-1 (sc-37902) were purchased
from Dharmacon and Santa Cruz Biotechnology,
respectively.
Antibodies
Antibodies against WHISTLE (sc-50151, Santa Cruz
Biotechnology), calmodulin-binding epitope (07-482,
Milipore), HSP90a (ab59459, Abcam), JMJD1C
(ab31215, Abcam), histone H3 (06-755, Milipore) and
b-actin (sc-47778, Santa Cruz Biotechnology) were
employed for immunoblot analysis, immunoprecipitation
or immunohistochemistry; FLAG (f3165, Sigma), myc
(sc-40, Santa Cruz Biotechnology) for immunocytochem-
istry, histone H3K4-me2 (07-030, Milipore), H3K9-me1
(07-450, Milipore)/-me2 (07-441, Milipore)/-me3 (17-625,
Milipore), H3K27-me2 (07-452, Milipore) and
H3K36-me2 (07-274, Milipore) were used for immunoblot
analysis or immunocytochemistry; and SF-1 (sc-28740,
Santa Cruz Biotechnology) was used for chromatin
immunoprecipitation (ChIP) analysis.
Cell lines and stable cell-line establishment
Mouse embryonic ﬁbroblast NIH3T3 cells and mouse
testis Leydig TM3 cells were maintained in Dulbecco’s
modiﬁed Eagle’s medium containing 10% fetal bovine
serum and 0.5% penicillin–streptomycin. In order to es-
tablish the cell-line stably expressing TAP-WHISTLE, the
NIH3T3 cells were transfected with pNTAP-WHISTLE
using Lipofectamine 2000 (Invitrogen), after which the
stably transfected clones were selected in media containing
2.5mg/ml of G418 (Sigma).
Tandem aﬃnity puriﬁcation and LC–MS/MS analysis
Tandem aﬃnity puriﬁcation (TAP) puriﬁcations were
conducted as described previously (16) with several modi-
ﬁcations using an InterPlay mammalian TAP system
(Stratagene). After the two-step puriﬁcation, the protein
samples were subjected to protease digestion, followed by
LC–MS/MS analysis.
HMTase assay
In vitro and in vivo HMTase assays were conducted as
previously described (15). For in vivo analysis, NIH3T3
cells were cotransfected with pcDNA6-WHISTLE,
pCMV-HSP90a using Lipofectamine 2000 (Invitrogen),
and the transfected cells were lysed with 1  RSB lysis
buﬀer for 1h at 4 C. The cell lysates were fractionated
in 14% SDS–PAGE, transferred, and each lysine speciﬁ-
city of histone H3 methylation was detected using rabbit
a-H3K4-me2, H3K9-me1/-me2/-me3, H3K27-me2 and
H3K36-me2 antibodies.
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Demethylase assays were conducted as described previ-
ously (17). H3K9-me1 peptide [TARK(me1)STG],
H3K9-me2 peptide [TARK(me2)STG] and H3K9-me3
peptide [TARK(me3)STG] were synthesized on the basis
of the N-terminal amino-acid sequences of histone H3
(Peptron). Synthetic peptides (0.1mg) were employed as
substrates in the demethylase assay.
Immunocytochemistry
NIH3T3 cells were grown on chamber slides and trans-
fected with pFLAG-JMJD1C expression plasmids using
Lipofectamine 2000. After 48h of transfection, the cells
were ﬁxed, incubated with each antibody, washed, stained
with SYTO61 and mounted.
Immunohistochemistry
The testis specimens were ﬁxed in 4% paraformaldehyde
in phosphate-buﬀered saline (PBS) for 12–14h at 4 C,
then washed, dehydrated and paraﬃn-embedded. The
6mM thick serial sections were obtained with a rotary
microtome. The sections were stained immunohisto-
chemically using an LSAB2 system-HRP kit (Dako), in
accordance with the manufacturer’s instructions. In
brief, the sections were deparaﬃnized, hydrated and
placed in peroxidase block solution for 10min. After
three washings in PBS, the sections were incubated with
a-WHISTLE and a-JMJD1C antibodies for 2h, respect-
ively, and treated for 20min with biotinylated link
solution, after which streptavidin–HRP solution was
applied for an additional 20min. As a negative control,
primary antiserum was replaced with PBS. The sections
were subsequently treated with DAB substrate–chromo-
gen solution for 10min and counterstained with Harris
hematoxylin. Images were photographed on a light micro-
scope (Olympus).
RT–PCR and quantitative PCR
Total RNA samples from each of the construct-
transfected TM3 cells and experimental mice at diﬀerent
developmental stages were extracted using Trizol reagent
(Invitrogen), in accordance with the manufacturer’s rec-
ommendations. One microgram of total RNA was used to
synthesize the cDNA. The cDNA synthesis was primed
using oligo-dT primer (Fermentas) and the quantiﬁed
cDNA was applied for p450c17, LHR, WHISTLE and
JMJD1C mRNA expression pattern analysis. The
primer sequences were as follows: p450c17: sense 50-CA
GCTGGCCATCTGCCTACAC-30 and antisense 50-ATC
TGGGGCCGACCAGAGAAT-30; LHR: sense 50-ATGG
GGCGGCGGGTCCCGGCT-30 and antisense 50-CTGT
GCATCTTCTCCAGGTAG-30; WHISTLE: sense 50-AA
GCTGGCAAGAAACTGCAT-30 and antisense 50-CAA
AGCCTCCTTGCTTTCAC-30; JMJD1C: sense 50-GAG
GACTTCAAGGCC-30 and antisense 50-AATTAGGTG
TCTTCC-30. The ampliﬁcation reaction was performed
under the following conditions: 35 cycles of denaturation
at 94 C, annealing at 58 C and extension at 72 C.
Dissociation curves were generated after each PCR run
to ensure that a single product of the appropriate length
was ampliﬁed. The mean threshold cycle (Ct) and standard
error were calculated from individual Ct values obtained
from three replicates per stage. The normalized mean Ct
was estimated as Ct by subtracting the mean Ct of
b-actin from that of p450c17. The value Ct was
calculated as the diﬀerence between control Ct and
values obtained at each sample. The n-fold change in




In the transcriptional activity assay (2.5 10
4 cells/well/
48-well plate at their 50–60% conﬂuence stage), TM3 cells
were cotransfected with 100–300ng of the expression
plasmid and 200ng of the SV40-driven reporter or
SF-1-RE-luc reporter plasmid using Lipofectamine 2000
reagents, again in accordance with the manufacturer’s rec-
ommendations. After 48h, the cells were harvested and
subjected to the luciferase assay (Promega). The amount
of DNA in each transfection was maintained at constant
levels via the addition of ﬁxed amounts of pcDNA3.0
vector.
In vitro transcription and translation reactions
For in vitro transcription and translation, the [
35S]-labeled
JMJD1C proteins were constructed using a coupled tran-
scription and translation (TNT) system (Promega).
In brief, 1mg of DNA was added directly to TNT rabbit
reticulocyte lysates, then permitted to react for 2h at
30 C. The reaction mixtures were then employed in a
GST-pull down assay, using GST-WHISTLE, GST and
TM3 cell lysates. The precipitated proteins were then
separated via 8% SDS–PAGE and autoradiographically
visualized.
Immunoprecipitation
For the interaction assays, the transfected cells were lysed
in RIPA lysis buﬀer and immunoprecipitated with a-myc
or a-SF-1 antibodies (Santa Cruz Biotechnology) and
protein A agarose beads (GenDEPOT). The bound
proteins were analyzed in immunoblots with a-JMJD1C,
a-WHISTLE and a-SF-1antibodies.
ChIP assay and quantitative PCR
The TM3 cells were transfected, harvested for 48h and
then cross-linked with 1% formaldehyde in the medium
for 10min at room temperature, followed by the addition
of 125mM glycine for 5min at RT. The samples were
sonicated and immunoprecipitated using the indicated
antibodies. The immunoprecipitates were eluted and
reverse cross-linked, after which the DNA fragments
were puriﬁed for PCR ampliﬁcation. Primer pairs were
selected for experimental studies of the potential site of
SF-1 in the 541-bp region (–837 to  296: sense 50-TTTC
AGGGGCCAGAAGGTG-30 and antisense 50-TCCTCC
CAGAGGCAAATGC-30) of mouse p450c17 promoter.
For p450c17 promoter exon region analysis, the primer sets
comprised the 454-bp region (+1 to+454: sense 50-CAGG
Nucleic Acids Research, 2010, Vol.38, No. 19 6391CTTGGAGACACTCCAGG A-30 and antisense 50-CAT
CTGGGGCCGACCAGAGAATT-30). The primer con-
centration employed for real-time PCR was 0.2mM/
25ml. The thermal cycler conditions were as follows:
15min of holding at 95 C, followed by three steps of
PCR for 50 cycles at 94 C for 15s, 60 C for 30s and
72 C for 30s (Corbett Research). The percentage
(Bound/Input) is percentage recruited to the target




Testosterone concentrations were assayed via a RIA tech-
nique, as described previously (18). In brief, TM3 cells
seeded onto 60-mm culture dishes were cultured for 24h
in DMEM medium supplemented with 10% FBS. Culture
medium was collected for radioimmunoassay (RIA) at the
appropriate time points after exchanging with fresh
medium containing 200ng/ml of LH, and the culture
media were then directly assayed with no additional puri-
ﬁcation. Each treatment group included duplicate
cultures, and each experiment was repeated at least
twice. The assay procedures were followed as described
previously using labeled testosterone ([1,2,6,7-3H]testos-
terone; 96Ci/mol) and progesterone ([1,2,6,7-3H] proges-
terone; 96Ci/mol) obtained from NEN.
Statistical analysis
The data were expressed as the means±SD of three or
more independent experiments. Statistical signiﬁcance
eﬀects (P<0.05) were evaluated with Microsoft EXCEL
software. Diﬀerences between groups were evaluated via
one-way analysis of variance (ANOVA), followed by
Student’s t-tests or Bonferroni’s tests, as appropriate.
RESULTS
Puriﬁcation of TAP-WHISTLE and interacting proteins
In an eﬀort to obtain greater insight into the in vivo
functions of WHISTLE, we developed NIH3T3 cell lines
that stably expressed TAP-tagged WHISTLE, and then
puriﬁed the WHISTLE-interacting complexes using a
TAP system. In an eﬀort to identify the interacting
complexes, the aﬃnity eluates were analyzed via SDS–
PAGE followed by silver staining, and subsequently
subjected to mass spectrometric analysis (Figure 1A).
Mass analysis revealed a sizeable collection of the
WHISTLE-interacting complexes, including HSP90a and
histone demethylase JMJD1C (Figure 1A and Supple-
mentary Table S1). Parts of the identiﬁed proteins were
immunoblotted using speciﬁc antibodies. Immuno-
precipitation (IP) assays were conducted to verify the
interactions between WHISTLE and the identiﬁed
proteins, HSP90a and JMJD1C, using NIH3T3 cell
extracts (Figure 1B). In a previous study, we reported
that WHISTLE was abundantly expressed in mouse
testes (14). Co-IPs have been conducted in mouse testis
Leydig TM3 cells using a-WHISTLE antibodies, and
pull-downs of endogenous JMJD1C and HSP90a
proteins were performed (Figure 1C). Considering the
results of our previous studies, we hypothesized that
WHISTLE-interacting HSP90a might operate as a
cofactor with WHISTLE to achieve maximal HMTase
activity (15). The transient transfection of
pcDNA6-WHISTLE elicited methylations of both
H3K4-me2 and H3K27-me2 as compared to what was
observed in mock vector-transfected cells (Figure 2A
and Supplementary Figure S1A). When pCMV-HSP90a
was cotransfected with WHISTLE, further increases in the
methylation of H3K4 and H3K27 were noted (Figure 2A
and Supplementary Figure S1A). No changes in the
methylation levels of H3K9 and H3K36 were noted
throughout the processes. The expressions of the
WHISTLE and HSP90a constructs employed in transfec-
tion were conﬁrmed by the results of immunoblotting
(Supplementary Figure S1B). The eﬀect of HSP90a on
the HMTase activity of WHISTLE was corroborated
further by the results of an in vitro HMTase assay. The
incubation of cold-SAM, histones and recombinant
WHISTLE yielded almost no enzyme activity. The
histone H3K4-me2 and H3K27-me2 methylating activities
of WHISTLE were shown to be increased upon the
addition of increasing quantities of puriﬁed HSP90a
(Figure 2B). Consistent results were observed when
[
14C]-SAM was employed as a methyl donor (Figure 2B,
phosphorimage). These results demonstrate that HSP90a
functions as a cofactor for the full HMTase activity of
WHISTLE.
Histone H3K9 mono- and di-methylation-speciﬁc
demethylase activity of JMJD1C
The phylogenic analysis of human JmjC-containing
proteins classiﬁed JMJD1C among the subfamily of
demethylases that includes JMJD1A (JHDM2A) and
JMJD1B (JHDM2B) (Figure 3A, upper panel). One of
the distinct domain characteristics of the JMJD1 family
in diﬀerent species is that they all harbor a zinc-ﬁnger
(ZF)-like domain, as well as a JmjC domain. Both Fe(II)
and a-ketoglutarate (a-KG)-binding sites are conserved
among JMJD1A orthologs, which indicates that these
proteins may exhibit H3K9-speciﬁc demethylase activity
(19). Sequence alignment of the mammalian JmjC
domain-harboring proteins from the JMJD1 family
showed that the position of the histidine residue is
highly conserved (Figure 3A, lower panel, boxed). In a
recent study, it was determined that JMJD1A eﬀects the
demethylation of H3K9-me1 and H3K9-me2 in embryon-
ic stem (ES) cells (20). JMJD1A evidences demethylase
activity on H3K9-me1 and H3K9-me2, and is also some-
times referred to as testis-speciﬁc gene A (TSGA) (21).
TSGA has been implicated in mouse spermatogenesis
and androgen receptor-mediated gene activation (17,22).
In order to evaluate the lysine speciﬁcity of demethylase
JMJD1C, TM3 cells were transiently transfected and
the nucleosomes were immunoblotted against speciﬁc
antibodies for H3K4-me2, H3K9-me1/-me2/-me3,
H3K27-me2 and H3K36-me2. We initially detected a re-
duction of H3K9-me2 as the consequence of JMJD1C
treatment; further immunoblot analysis revealed that the
6392 Nucleic Acids Research, 2010, Vol.38, No. 19levels of H3K9-me1 were also reduced, whereas the level
of H3K9-me3 remained unaltered (Figure 3B and
Supplementary Figure S2A). No demethylase activities
of JMJD1C to H3K9-me1/H3K9-me2 were noted with a
JMJD1C point mutant (H2326A), which illustrates the
importance of the conserved residue in the JmjC domain
in regard to demethylase activity (Figure 3B). Deletions
of the JmjC domain (JMJD1C-N) or ZF-like motif
(JMJD1C-C) failed to reduce the levels of H3K9-me1/
-me2 in both immunoblot analyses (Supplementary
Figure S3A–C). The lysine speciﬁcity of JMJD1C was
also evaluated via immunocytochemistry in this study.
Ectopic JMJD1C expression induced a loss of
H3K9-me1/-me2, whereas no such reductions in the
levels of H3K9-me3, H3K4-me2, H3K27-me2 and
H3K36-me2 were observed (Figure 3C). The
Figure 1. WHISTLE interacts with HSP90a and JMJD1C. (A) Schematic representation of TAP-WHISTLE puriﬁcation. Upper panel: veriﬁcation
of CT (TAP-empty vector) and TAP-WHISTLE stably expressing NIH3T3 cells by a-calmodulin antibody. Lower panel: silver staining of the ﬁnal
puriﬁed sample on 9–16% SDS gradient gel and immunoblot analysis of identiﬁed proteins using each of the indicated antibodies. (B) Interaction
between WHISTLE and HSP90a, JMJD1C. Veriﬁcation of JMJD1C and HSP90a interaction with WHISTLE via co-immunoprecipitation in
NIH3T3 cells. Co-IPs were conducted using a-myc (WHISTLE) antibodies, after which immunoblots were performed using a-HSP90a and
JMJD1C antibodies. (C) Endogenous interaction between WHISTLE and JMJD1C and HSP90a, respectively. HSP90a and JMJD1C with TM3
cells were immunoprecipitated using a-WHISTLE and a-IgG, then immunoblotted against a-JMJD1C and a-HSP90a antibodies.
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JMJD1C (H2326A) did not inﬂuence the levels of
H3K9-me1/-me2 (Figure 3D). Histones were subjected
to in vitro demethylase assays using puriﬁed
GST-JMJD1C. The results of immunoblot analysis
demonstrated that H3K9-me1/-me2 underwent a signiﬁ-
cant reduction in methylation levels as compared to
the H3K9-me3, H3K27-me2 and H3K36-me2 samples
(Figure 3E and Supplementary Figure S2B). In an eﬀort
to further evaluate the H3K9-me1 and H3K9-me2 speci-
ﬁcity of JMJD1C, H3K9-me1/-me2/-me3 peptides were
analyzed via demethylase assays. Mass spectrometry
analysis demonstrated that H3K9-me1/-me2 peptides
were converted to mono- and unmethylated peptides
after incubation with JMJD1C (Figure 3F). When the
H3K9-me3 peptides were incubated with JMJD1C, no
demethylation was detected.
Expression proﬁle of WHISTLE and JMJD1C during
mouse testis development
To evaluate the localization and expression patterns of
WHISTLE and JMJD1C in the testes of mice, we
probed sections of the testicular tissues of 2 and 6
weeks’ postnatal mice with an antiserum against
JMJD1C and WHISTLE. The postnatal 2- and
6-week-old mice were selected because both genes were
expressed at suﬃcient levels around these periods.
Immunohistochemical studies of mouse testis have
demonstrated that WHISTLE was abundant in the inter-
stitial cells of Leydig and vascular endothelial cells at 2
weeks of age staining (Figure 4A, brown color), and
WHISTLE-positive cells were less abundantly detected
in the 6-week-old sections. As compared to WHISTLE,
speciﬁc immunoreactions of JMJD1C evidenced much
stronger signals in the spermatogonia and primary sperm-
atocyte within the seminiferous tubules and the
interstitum in the 6-week-old sections (Figure 4A). It is
interesting to note that these two proteins evidence
partial cell-type speciﬁcity within the testicular tissues,
even though they are also expressed in the same types
of cells.
To further evaluate the physiological functions of
WHISTLE and JMJD1C in the development of mouse
testes, we evaluated their expression patterns in postnatal
developmental stages of the mouse testes. The results of
RT–PCR analysis demonstrated that WHISTLE mRNA
was expressed abundantly in the very early stages of de-
velopment, and was reduced gradually for up to 60 days
after birth (Figure 4B). By way of contrast, JMJD1C
mRNA was detected at very low levels during early devel-
opmental stages, and then concentrations began to
increase at 7 days, with high expression levels being
detected after 30 days (Figure 4B). Because the cholesterol
side chain cleavage enzyme, p450c17 and the pituitary go-
nadotropin LH receptor, LHR, are important regulators
and diﬀerentiation markers of steroidogenesis, the expres-
sion patterns of these proteins were assessed as controls.
As LH treatment induces testosterone secretion in TM3
cells during steroidogenesis, we treated the TM3 cells with
LH and then evaluated the expression patterns of
WHISTLE and JMJD1C. Abundant WHISTLE expres-
sion was maintained until 1h after treatment, followed by
a signiﬁcant decline after 2h (Figure 4C). By way of
contrast, the expression of JMJD1C mRNA evidenced a
steady increase beginning 1h after treatment. Similar
protein expression patterns of WHISTLE and JMJD1C
were observed on immunoblot analysis (Figure 4D).
Figure 2. HSP90a functions as a cofactor for the full HMTase activity
of WHISTLE. (A) In vivo HMTase activity. pcDNA6-WHISTLE and
pCMV-HSP90a were transfected into NIH3T3 cells, and altered histone
methylation patterns were detected on immunoblot analyses using
speciﬁc antibodies. Equal amount of analyzed samples were veriﬁed
by immunoblot against a-histone antibodies. (B) In vitro HMTase
assay with increasing concentration of HSP90a proteins. The
amounts of HSP90a proteins, histone H3 and histone methylation
status were detected via immunoblots using the indicated antibodies.
The phosphorimage shows methylated histone H3 via the same in vitro
HMTase with methyl donor isotope. Core histones used for assays were
shown by Coomassie Blue staining.
6394 Nucleic Acids Research, 2010, Vol.38, No. 19Figure 3. Histone H3K9 speciﬁc demethylase activity of JMJD1C. (A) Upper panel: phylogenetic analysis based on protein sequence data of the
JMJD1 and JMJD2 families. Schematic representation of the JMJD1C with functional domains is shown. Lower panel: alignment of parts of the
JmjC domain of the human and mouse JMJD1 family members. The position of catalytically inactive point mutation changing an amino acid 2326
from histidine to alanine in the JmjC domain of demethylase JMJD1C is shown. Conserved amino-acid residues are shown in black and similar
residues are shaded in grey. Indicated asterisk and hash marks represent Fe(II) and a-ketoglutarate (a-KG) binding site, respectively. (B) JMJD1C
and JMJD1C (H2326A) were transfected in TM3 cells, and demethylation activities were analyzed via immunoblot analysis with indicated antibodies.
(C) TM3 cells transfected with ﬂag-JMJD1C were immunostained with antibodies against ﬂag-JMJD1C and the indicated histone H3 lysine residues
with diﬀerent methylation marks. SYTO61 staining represents nucleosomes. Arrowheads indicate transfected cells. (D) TM3 cells were transfected
with myc-JMJD1C (H2326A) and stained with a-myc, a-H3K9-me1 and a-H3K9-me2. Arrowheads indicate the transfected cells. (E) In vitro
demethylase assays of GST-puriﬁed JMJD1C were conducted with core histones using a-KG, ascorbate and Fe(II) as cofactors, then immunoblotted
against the indicated antibodies. (F) H3K9-me1/-me2/-me3 peptides were incubated with GST-JMJD1C or GST and the modiﬁed peptides were
analyzed via MALDI-TOF mass spectrometry.
Nucleic Acids Research, 2010, Vol.38, No. 19 6395Collectively, these data indicate that WHISTLE and
JMJD1C may perform distinct roles in testis
steroidogenesis, via the regulation of target gene transcrip-
tions via speciﬁc modiﬁcations of histone methylation
status.
Regulatory role of WHISTLE and JMJD1C in
SF-1-mediated mouse steroidogenesis
In an eﬀort to elucidate more thoroughly the eﬀects of
JMJD1C on WHISTLE-mediated transcriptional repres-
sion, we conducted a transient transfection assay using the
pCMX-Gal4-SV40 reporter system. As was previously
reported, transfection with WHISTLE repressed luciferase
activity and the overexpression of shWHISTLE
ameliorated WHISTLE-mediated repression and fur-
ther activated the transcription of SV40 in TM3 cells
(Figure 5A). We then attempted to determine whether
WHISTLE-interacting JMJD1C could reverse the
observed WHISTLE-mediated transcriptional repression,
by demethylating H3K9 methylation. When transfected
alone, JMJD1C moderately induced SV40 transcription
to levels similar to those of shWHISTLE (Figure 5A).
The signiﬁcant reduction in transcription noted with
si-JMJD1C treatment conﬁrmed the role of JMJD1C
in SV40 transactivation. As anticipated, increasing quanti-
ties of JMJD1C overexpression signiﬁcantly reversed
WHISTLE-mediated transcriptional repression in a
dose-dependent manner (Figure 5A). These results dem-
onstrate that JMJD1C may function as a substitute
for WHISTLE-mediated transcriptional repression
activity for activation, via the demethylation of H3K9
methylation.
Figure 3. Continued.
6396 Nucleic Acids Research, 2010, Vol.38, No. 19As an orphan nuclear receptor, steroidogenic factor 1
(SF-1) has been shown to regulate the expression of many
of the genes involved in steroidogenesis, including CYP
variants and StAR (23). These genes perform important
roles in the function and development of reproductive
tissues including the adrenals and gonads (12). The diﬀer-
ential expression patterns of WHISTLE and JMJD1C in
the mouse testes during developmental stages, as well as
the observed induction of steroidogenesis, compelled us to
determine with more speciﬁcity whether or not WHISTLE
and JMJD1C are involved in steroidogenesis via inter-
actions with SF-1. In order to characterize in detail the
functions of WHISTLE and JMJD1C in SF-1-mediated
steroidogenesis, we attempted to determine the manner in
which these proteins interact with one another. Interaction
assays using in vitro transcription-translated JMJD1C and
immunoprecipitates against WHISTLE were conducted,
and we determined that WHISTLE and JMJD1C did
not interact directly with one another; rather, they
appear to associate with one another in a protein
complex in vivo (Figure 5B and C). Co-IP assays were
conducted to conﬁrm complex formation among
WHISTLE, JMJD1C and SF-1 (Figure 5C). We further
analyzed the mechanisms underlying SF-1-mediated
WHISTLE and JMJD1C interaction prior to and after
LH treatment. The IP assays showed that SF-1 interacted
strongly with WHISTLE prior to LH treatment and then
switched to JMJD1C after the induction of steroido-
genesis by LH (Figure 5D).
The complex formation and diﬀerential interactions
between SF-1 and WHISTLE/JMJD1C indicate that
WHISTLE and JMJD1C are involved in steroidogenesis
via the regulation of SF-1 transcription. We conducted a
transient transfection assay using the SF-1-RE luciferase
Figure 4. WHISTLE and JMJD1C are involved in mouse testis development. (A) Immunohistochemical analysis of WHISTLE and JMJD1C
expression in 2- and 6-week-old mouse testes. Arrowheads indicate the expression of WHISTLE and JMJD1C in diﬀerent stages of mouse testis
tissue, as indicated. (B) The expression levels of WHISTLE, JMJD1C, p450c17 and LHR in indicated postnatal mouse testes are detected via RT–
PCR. The quantiﬁed RT–PCR results are shown in the upper panel. (C) Expression pattern of WHISTLE and JMJD1C in diﬀerent time points after
LH (200ng/ml) treatment in TM3 cell. Upper panel indicates quantitated RT–PCR results and the lower panels indicate RT–PCR analysis. (D)
Western blot analysis of WHISTLE and JMJD1C protein expression levels in LH-treated TM3 cells. The quantiﬁcation of western blots is shown in
the upper panel. All data are shown as means±SD; n=3 at each time point. **P<0.01 and ***P<0.001.
Nucleic Acids Research, 2010, Vol.38, No. 19 6397Figure 5. WHISTLE and JMJD1C exert diﬀerent eﬀects on transcriptional activity of SF-1. (A) TM3 cells were transfected with pCMX-Gal4-SV40
and indicated DNA constructs and siRNA, and their cell extracts were assayed for luciferase activity. The results are representative of at least ﬁve
independent experiments (±SD). **P<0.01 and ***P<0.001, compared with untreated control. (B) In vitro translated JMJD1C proteins were
permitted to interact with GST-WHISTLE proteins and TM3 cell nuclear extract was added, followed by the analysis of the proteins on 10% SDS–
PAGE gels. (C) In vivo interaction analysis between WHISTLE and JMJD1C and SF-1 via co-IP in TM3 cells. TM3 cells were transfected with
myc-WHISTLE, JMJD1C and SF-1. IP was performed using a-myc antibodies, after which immunoblot analysis was conducted using a-JMJD1C
and SF-1 antibodies. (D) Co-IP between WHISTLE and JMJD1C with SF-1 prior to and after LH treatment in TM3 cells. (E and F) Regulatory
eﬀects of WHISTLE and JMJD1C through SF-1-mediated transcription. TM3 cells were transfected with SF-1 (E) or treated with si-SF-1 (F) and a
three copy SF-1-RE-luc, and indicated DNA constructs and siRNAs. All data are expressed as means±SD; n=5. *P<0.05 and ***P<0.001.
6398 Nucleic Acids Research, 2010, Vol.38, No. 19reporter system. As had been anticipated, the transfection
of SF-1 into TM3 cells resulted in the activation of
luciferase activity. Consistent with its transcriptional re-
pression activity, WHISTLE was shown to repress the
transcriptional activity of SF-1 (Figure 5E). The transcrip-
tional repressive activity of WHISTLE was clearly veriﬁed
by two independent RNAi-mediated knock-downs,
shWHISTLE and si-WHISTLE treatment, by virtue of
the recovery of SF-1-mediated transcriptional activity
(Figure 5E and Supplementary Figure S4). Interestingly,
the transcriptional activation of SF-1 was further
enhanced when JMJD1C was cotransfected with SF-1
(Figure 5E). Treatment with si-JMJD1C downregulated
the JMJD1C-induced enhancements of transcriptional ac-
tivation. Identical results were noted when diﬀerent 293T
cell lines were used, although the overall luciferase
activities were lower than those of the TM3 cell lines
(data not shown). The knockdown of the SF-1 by si-SF-
1 deﬁnitively abolished the transcriptional activa-
tion induced by endogenous SF-1, and none of the
tested reagents (WHISTLE, JMJD1C, shWHISTLE,
si-JMJD1C or si-SF-1) evidenced their anticipated ef-
fects in TM3 cells (Figure 5F and Supplementary Figure
S5). Taken together, these ﬁndings demonstrate that
WHISTLE may repress the early stages of steroidogenesis
by inhibiting the SF-1-mediated transactivation of target
genes, and also that JMJD1C induces the transcriptional
activation of SF-1 in later stages of steroidogenesis.
ChIP analysis with real-time PCR using testicular cells
revealed that WHISTLE and JMJD1C were recruited to
speciﬁc response elements of p450c17 at diﬀerent times
during steroidogenesis. We noted that WHISTLE is spe-
ciﬁcally recruited to the p450c17 promoter region prior to
LH treatment, and that during steroidogenesis by LH
treatment, the binding of WHISTLE to the promoter
was abolished (Figure 6A, a). On the other hand,
JMJD1C did not occupy the p450c17 promoter prior
to LH treatment, and then evidenced signiﬁcantly
elevated recruitment afterward (Figure 6A, a). ChIP
with real-time PCR analysis showed stronger recruitment
of the WHISTLE cofactor, HSP90a, on the p450c17
promoter prior to LH treatment; this is consistent with
the stronger recruitment of WHISTLE observed prior to
LH treatment (Figure 6B). Comparable results were noted
when we assessed histone methylation status on the
p450c17 promoter region. Real-time PCR with the ChIP
assay showed that histone H3K4-me2 and H3K27-me2
methylation levels on the p450c17 promoter region
were signiﬁcantly downregulated after LH treatment
(Figure 6C). The methylation level of histone H3K9-me2
was also reduced, thus reﬂecting the increased level of
JMJD1C after LH treatment (Figure 6C, a). These
results are consistent with our data, which revealed
strong recruitment of the H3K4-me2 and
H3K27-me2-methylating HMTase WHISTLE to the
p450c17 promoter before LH signaling and subsequent
replacement by JMJD1C. We then conﬁrmed that both
WHISTLE and JMJD1C regulate steroidogenic markers
via SF-1-mediated transcription. The results of quantita-
tive PCR after ChIP analysis demonstrated that SF-1 is
strongly recruited to the p450c17 promoter both prior to
and after LH treatment, although recruitment was
stronger after LH treatment. This indicates that both
WHISTLE and JMJD1C require the presence of SF-1
for its role in steroidogenesis (Figure 6D, a). On the
contrary, no changes were detected in WHISTLE/
JMJD1C, SF-1 recruitment or histone methylation levels
in the exonic region of p450c17 (Figure 6A, C and D, b).
Consistent with the results obtained in the SF-1 response
element reporter assay with si-SF-1, the depletion of SF-1
by si-SF-1 in TM3 cells also resulted in failure to recruit
WHISTLE and JMJD1C to the p450c17 promoter prior
to and after LH treatment, respectively (Figure 6E).
Having established the observation that WHISTLE and
JMJD1C were recruited to the p450c17 promoter and
regulated p450c17 transcription during SF-1-mediated
steroidogenesis, we attempted to determine whether
WHISTLE and JMJD1C can regulate the expression of
p450c17. As anticipated, the overexpression of WHISTLE
downregulated the expression of p450c17, and JMJD1C
signiﬁcantly enhanced the expression of p450c17 (Figure
6F). Knockdown by siRNA clearly conﬁrmed the en-
dogenous role of WHISTLE and JMJD1C on p450c17
transcription (Figure 6F). Together, these results
demonstrated that SF-1 performs a crucial function in
the recruitment of WHISTLE and JMJD1C to the target
promoter p450c17 during the development of mouse
steroidogenesis.
In an eﬀort to elucidate in greater detail the regulatory
roles of WHISTLE and JMJD1C in mouse testis develop-
ment, TM3 cells were transiently transfected with
WHISTLE or JMJD1C and subjected to LH treatment;
following LH treatment, the testosterone concentrations
were assayed via RIA. The treatment of TM3 cells with
LH increased testosterone concentration to some degree in
the control cells. When the WHISTLE-overexpressing
cells were treated with LH, testosterone expression was
reduced (Figure 7A). Consistent with the above results,
when LH treatment was administered in conjunction
with JMJD1C, steroidogenesis was induced to a signiﬁ-
cant degree in the TM3 cells (Figure 7A). The RNAi-
mediated knockdowns of both WHISTLE and JMJD1C
relieved the eﬀects of the overexpressed and endogenous
proteins. The eﬀects of each transfection proved to be
marginal in the absence of LH treatment. These results
indicate that WHISTLE and JMJD1C contribute to the
transcriptional regulation of SF-1-mediated steroido-
genesis via the switching of methylation marks on the
promoter of the target gene, and are involved in the de-
velopment of mouse testes (Figure 7B).
DISCUSSION
Since the identiﬁcation of the H3K4-speciﬁc LSD1, a
growing number of histone demethylases with diﬀerent
speciﬁcities have been characterized. Classes of
demethylases that harbor the JmjC domain have recently
been the focus of active investigations. Approximately 28
human Jmj-harboring proteins that appear relevant to the
dynamic regulation of histone methylation have been
identiﬁed thus far (5). The aberrant regulation of histone
Nucleic Acids Research, 2010, Vol.38, No. 19 6399Figure 6. SF-1-mediated recruitments of WHISTLE and JMJD1C in p450c17 promoter. (A) Schematic diagram of primer pairs in ChIP analysis
(upper panel). Arrows indicate the primers for real-time PCR ampliﬁcation. ChIP analyses of the p450c17 with or without LH-treated TM3 cells were
conducted using a-WHISTLE and a-JMJD1C antibodies and examined by real-time PCR (lower panel). The recruitments of WHISTLE and
JMJD1C in the p450c17 promoter region (a) and p450c17 exonic region (b) were normalized by input. The results are expressed as the
means±SD; n=3. ***P<0.001. (B) ChIP analyses of the p450c17 with or without LH-treated TM3 cells were conducted using a-HSP90a
antibodies. The immunoprecipitated DNA fragments were real-time PCR ampliﬁed using primers for the p450c17 promoter (a). The results are
expressed as the means±SD; n=3. *P<0.05. (C) ChIP assay and real-time PCR for the methylation status of histone H3K4-me2, K9-me2,
K27-me2 and K36-me2 in the p450c17 promoter (a) and p450c17 exonic region (b) of TM3 cells treated prior to and after LH treatment. Histone
methylation levels were normalized by input. The results are expressed as means±SD; n=3.(D) Real-time PCR analysis following ChIP assays for
SF-1 recruitment in p450c17 promoter prior to and after LH treatments. SF-1 recruitment levels in the p450c17 promoter (a) and exonic region (b)
were normalized by input. Results were expressed as the means±SD; n=3. ***P<0.001. (E) Recruitment of WHISTLE and JMJD1C in the
p450c17 promoter were analyzed via ChIP assay and real-time PCR using si-SF-1 treated TM3 cells in the absence of SF-1 prior to and after LH
treatments. The results are expressed as means±SD; n=3. *P<0.05 and **P<0.01. (F) The expression levels of p450c17 in each
construct-transfected cell via real-time PCR. Results are expressed as means±SD; n=3. *P<0.05, **P<0.01 and ***P<0.001.
6400 Nucleic Acids Research, 2010, Vol.38, No. 19demethylases causes a variety of human diseases,
including certain cancers and developmental defects
(5,24). JMJD1C was originally referred to as thyroid
hormone receptor-interacting protein 8 (TRIP8) (25).
The other JMJD1 family demethylases, testis-speciﬁc
gene A (TSGA, JMJD1A) and JMJD1B (5qNCA), were
also identiﬁed and implicated as playing a role in mouse
spermatogenesis and human hematopoiesis, respectively
(21,26). The JMJD1C variant s-JMJD1C was identiﬁed
previously as an androgen receptor-interacting coacti-
vator, and its observed reduced expression in human
breast cancer is suggestive of its functions in tumor sup-
pression (27).
In this study, we puriﬁed the HMTase WHISTLE inter-
acting complex via an aﬃnity puriﬁcation TAP strategy,
and isolated proteins with a variety of biological func-
tions, including transcriptional regulation. Among them,
we identiﬁed HSP90a as a co-factor for the full H3K4-
and H3K27-methylating activity of WHISTLE. A recent
report has demonstrated that the carcinogenesis-related
HMTase, SMYD3, requires the HSP90a protein to exert
its biological activities, which include histone methylation
Figure 6. Continued.
Nucleic Acids Research, 2010, Vol.38, No. 19 6401(28). Via diﬀerent analysis methods, we further identiﬁed
the JMJD1 family demethylase, JMJD1C, as an
H3K9-me1/-me2 speciﬁc demethylase. The diﬀerential ex-
pression patterns of WHISTLE and JMJD1C during the
developmental stages of the mouse testis were also
identiﬁed in greater detail in this study. Consistent
results were noted when we induced steroidogenesis in
mouse testis TM3 cells with LH. We then demonstrated
that HMTase WHISTLE and demethylase JMJD1C dif-
ferentially regulated the transcription of a mouse
steroidogenic target gene, p450c17, during testis develop-
ment. These results strongly suggest that WHISTLE may
perform a repressive regulatory role during the early
stages of steroidogenesis, whereas JMJD1C exerts
positive eﬀects as steroidogenesis proceeds. Finally, we
identiﬁed the SF-1-mediated steroidogenesis regulatory
network via the addition and removal of speciﬁc methyla-
tion marks by HMTase WHISTLE and demethylase
JMJD1C.
Based on our results, we propose that SF-1 is able to
bind to H3K4, H3K27 methyltransferase WHISTLE and
H3K9 demethylase JMJD1C. During the early stages of
steroidogenesis, H3K4 and H3K27 methyltransferase
WHISTLE binds to SF-1 and negatively regulates the
transcription of the steroidogenic marker, p450c17.
Upon the induction of steroidogenesis by LH, the inter-
action between SF-1 and WHISTLE is signiﬁcantly
reduced. On the other hand, the recruitment of H3K9
demethylase JMJD1C via SF-1 begins to increase with
progressing development of the mouse testes (Figure
7B). The presence of SF-1 at the p450c17 promoter prior
to LH treatment warrants further studies designed to
identify in detail the mechanisms underlying SF-1-
mediated p450c17 transcriptional regulation by LH signal-
ing and histone modiﬁcation marks. Consistent with our
results, coordinate regulations of histone methylation and
demethylation for the ﬁne control of target gene transcrip-
tion have been recently reported by other researchers. The
diﬀerential regulation of hematopoietic cell development
by histone demethylase LSD1 and methyltransferase
hSET1 have both been previously described (29). H3K27
methylating Polycomb-Repressive Complex 2 (PRC2) and
H3K4 demethylase Rbp2 (Jarid1a) have been proposed
to perform a role in mouse ES cell diﬀerentiation (10).
The importance of T-box-mediated interactions between
H3K4 methyltransferase and H3K27 demethylase
activities were identiﬁed via the association of human de-
velopmental defects with disruptions of the interaction
(11). Interestingly, a recent ﬁnding has demonstrated
that the proper balance between Set1-mediated H3K4
methylation and H3K4 demethylation by Jhd2 is
regulated by another histone modiﬁcation—namely,
polyubiquitination mediated by the E3 ubiquitin ligase,
Not4 (30). Collectively, our results provide evidence for
the HMTase WHISTLE-interacting complex, including
H3K9-me1/2 demethylase JMJD1C and WHISTLE
cofactor HSP90a. More importantly, two distinct and an-
tagonistic activities function as transcriptional activators
or repressors of the steroidogenesis target gene, p450c17,
and demonstrate their transcriptional regulatory functions
in the development of mouse testes via interactions with
SF-1. Further studies will be necessary to provide infor-
mation regarding physiological implications of the delicate
balances pertaining under various epigenetic modiﬁca-
tions, including histone methylation.
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